OraRisk® CT/NG is the most sensitive way to test for one of the emerging STDs, Chlamydia trachomatis (CT) and or Neisseria gonorrhea (NG) of the oropharynx. These conditions may be asymptomatic or involve only mild pharyngitis, yet the consequences of an unchecked infection may be severe and are transmissible to partners and others who share intimate contact.
OraRisk® CT/NG provides highly sensitive detection of either or both Chlamydia trachomatis or Neisseria gonorrhea and the report will include interpretative comments with specific recommendations for treatment. All of our salivary diagnostic tests can be ordered from the same simple oral rinse collection.
*OraRisk® CT/NG is not currently available in the State of New York.